REYKJAVIK, Iceland, June 27, 2007 (PRIME NEWSWIRE) -- Actavis Group (OMX:ACT), the international generic pharmaceuticals company, today announced that it has launched Ondansetron Tablets in the U.S. Actavis will market the product under an agreement with Natco Pharma Limited. Distribution of the product will commence immediately.
